INTRODUCTION {#s1}
============

Cathepsin-D is an aspartic endopeptidase, a type of lysosomal proteolytic enzyme found in almost all animal cells. In cells, it is localized in the endoplasmic reticulum or endosome as a soluble fraction or in a membrane-bound form[@r1]^)^. Cathepsin-D is synthesized in the rough endoplasmic reticulum as an inactive precursor, preprocathepsin-D, and after removal of the signal peptide, mannose 6-phosphate is tagged in the face cisternae of the Golgi to form procathepsin-D. This precursor is then transferred to the late endosome, forming the single-chain intermediate active enzyme form, after cleavage of the N-terminal propeptide under acidic conditions. Procathepsin-D is further degraded by the lysosome into a light chain and a heavy chain, which are the mature forms that demonstrate proteolytic activity[@r2],[@r3],[@r4]^)^.

Although an in vitro experiment revealed that cathepsin-D degrades connectin, which is localized in the sarcomere I-band[@r5]^)^, Z-band[@r6]^)^, myosin, α-actinin, tropomyosin, troponin T, and troponin I[@r7], [@r8]^)^, the role and localization of cathepsin-D in skeletal muscle remain largely unknown. Therefore, this study investigated the localized characteristics of cathepsin-D.

Cathepsin-D has previously been considered to be responsible for the nonspecific proteolysis in lysosomes. However, studies involving cathepsin-D knockout mice showed normal growth without any abnormalities from after birth to 2 weeks, although growth cessation was observed at 3 weeks. These animals died approximately 26 days after birth[@r9]^)^, suggesting that cathepsin-D specifically catalyzes the limited degradation of proteins that are essential for growth or homeostasis and is also involved in signal transduction pathways associated with survival.

In staurosporine-induced apoptosis of fibroblasts, cathepsin-D specifically cleaves Phe24, Trp48, and Phe183 of an apoptosis induction factor, Bid, resulting in its activation, and this, leads to the release of cytochrome c from the mitochondria as well as the induction of apoptosis[@r10]^)^. Furthermore, in naphthazarin-induced apoptosis of human fibroblasts, leakage of cathepsin-D was observed in the cytoplasm[@r11]^)^, and overexpression of inactive cathepsin-D suppresses H~2~O~2~-induced apoptosis[@r12]^)^. Based on these research results, cathepsin-D was revealed to be involved in not only the signal transduction pathway for cell survival but also the signal transduction pathway for apoptosis.

As for apoptosis induced by disuse muscle atrophy, apoptosis caused by immobilization-induced limb muscle atrophy decreased in caspase-3 knockout mice[@r13]^)^. In the case of denervation-induced atrophied muscle, the amount of apoptosis-inducing factor released from the mitochondria decreased, and apoptosis was suppressed[@r14]^)^. However, the involvement of cathepsin-D in the apoptosis mechanism induced in disuse muscle atrophy remains uncertain.

In our previous study describing the preventive method for disuse muscle atrophy using low-temperature environment (LTE) therapy, it was revealed that rats with hindlimb unloading (HU) treated with LTE therapy acclimated to low temperatures without shivering, and the progress of muscle atrophy in the soleus was reduced in comparison with that in HU rats kept in a normal-temperature environment[@r15]^)^. However, LTE therapy for HU rats caused the occurrence of apoptosis in the soleus muscle as a side effect; histological analysis revealed cathepsin-D leakage in the caspase-3-positive myofibers in HU in an LTE (HULT). These were assumed to be associated with apoptosis, which is caused by LTE[@r16]^)^, although the role of cathepsin-D in myofiber survival and death is unclear. Hence, the present study revealed histological and biochemical characterizations of the expression of cathepsin-D in the normal soleus muscle and in the soleus muscle of HU rats treated using LTE therapy.

SUBJECTS AND METHODS {#s2}
====================

This investigation was conducted in accordance with the ethical guidelines for the experimental treatment of animals of Hiroshima University.

Nine-week-old male Wistar rats weighing 278 ± 8 g were housed in individual cages and randomly assigned to four groups (5 rats/group). Rats underwent hindlimb unloading in a low-temperature environment (10 °C, HULT) for 3 weeks, whereas the control groups was not subjected to hindlimb unloading and was maintained in a normal-temperature environment (25 °C, CON). Hindlimb unloading was achieved by elevating the hindlimbs and preventing them from touching a supporting surface. The forelimbs maintained contact with a grid floor, which allowed the animals a full range of motion. Food and water were provided *ad libitum*.

At the end of the experimental period, the rats were anesthetized with an intraperitoneal injection of 50 mg/kg pentobarbital sodium[@r17]^)^ (Abbott Laboratories, North Chicago, IL, USA), weighed, and sacrificed by laparotomy followed by transection of the abdominal aorta. The soleus muscles were immediately excised and cut transversely into two segments. Each segment was individually mounted on cork using optimum cutting temperature compound (Sakura Finetek USA, Torrance, CA, USA), and then the blocks were rapidly snap frozen in isopentane cooled in liquid nitrogen and stored at −80 °C.

To compare the ratio of fiber type compositions in the soleus muscle of CON and HULT rats, 10-μm-thick serial transverse cryosections were cut from tissue blocks using a cryostat microtome at −25 °C and were fixed in cold acetone at 4 °C. The sections were stained using the VECTASTAIN Elite ABC system (Vector Laboratories, Burlingame, CA, USA) according to the manufacturer's protocol. Briefly, the endogenous peroxidase activity in tissue was blocked by incubation in 0.3% (v/v) hydrogen peroxide (H~2~O~2~) in absolute methanol, and then nonspecific immunoglobulin (Ig) binding sites were blocked by 1% normal bovine serum albumin (BSA, Sigma-Aldrich, St. Louis, MO, USA) in phosphate-buffered saline (PBS). The sections were immersed in a mouse monoclonal anti-slow myosin antibody (Sigma) or a mouse monoclonal anti-fast myosin antibody (Sigma) in PBS containing 1% BSA at RT, incubated in a secondary biotinylated anti-mouse IgG, and treated with an ABC reagent. Immunoreactivity was visualized using Tris-HCl buffer containing 0.1% 3,3′-diaminobenzidine tetrahydrochloride (DAB) (Sigma) and 0.05% H~2~O~2~. Myofiber types were manually classified for almost all myofibers using a light microscope, and the total number of slow- and fast-type myofibers were counted using the NIH Image Ver. 1.62 (National Institutes of Health) software.

To observe the cathepsin-D and fast myosin expression in the apoptotic myofibers of atrophied soleus muscle, immunofluorescence staining was performed by the same procedure as described above. Some sections were routinely stained with hematoxylin and eosin (HE) prior to fixation[@r18]^)^. The primary antibodies used were a rabbit polyclonal anti-caspase-3 antibody (Promega, Madison, WI, USA), a mouse monoclonal anti-dystrophin antibody (Novocastra Laboratories, Newcastle, UK), a mouse monoclonal anti-cathepsin-D antibody (Transduction Laboratories, Lexington, KY, USA), a mouse monoclonal anti-slow myosin antibody (Sigma), and a mouse monoclonal anti-fast myosin antibody (Sigma). The secondary antibodies used were Alexa 488-conjugated anti-mouse IgG or Alexa 546-conjugated anti-rabbit IgG (Molecular Probes, Eugene, OR, USA). For double-labeling immunofluorescence, incubations with primary and secondary antibodies were performed as described above. The sections were examined using a confocal laser scanning microscope (LSM-510, Carl Zeiss, Jena, Germany). The numbers of caspase-3-positive myofibers were counted on digitized images from fluorescence microscopy.

Internucleosomally degraded DNA was detected by the terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling (TUNEL) technique (DeadEndTM Fluorometric TUNEL System, Promega) according to the manufacturer's instructions.

For western blot analyses, whole muscle lysates were isolated by homogenizing freshly excised muscle in lysis buffer on ice. Homogenates were centrifuged at 10,000 ×g for 10 min at 4 °C to remove nuclear fragments and tissue debris without precipitating the plasma membrane, and the supernatants were used. The protein concentrations were determined by the Bradford method[@r19], [@r20]^)^. All proteins were denatured by boiling at 90 °C in sample buffer. Denatured proteins were electrophoresed in 12.5% SDS-polyacrylamide gels and transferred to nitrocellulose membranes (Bio-Rad, Hercules, CA, USA). The membranes were blocked overnight with blocking buffer, incubated in an anti-cathepsin-D antibody or an anti-actin antibody (sigma), probed with a secondary biotinylated anti-mouse antibody, and incubated with ABC reagent. Labeling was detected with 0.01% DAB and 0.05% H~2~O~2~ in 50 mM Tris--HCl buffer. Quantification of the signal was performed by densitometric analysis using the NIH Image (Ver. 1.59) software.

All values are expressed as the mean ± SE. The results obtained from all experiments were analyzed by Welch's t-test[@r21], [@r22]^)^. Data were considered significantly differrent when p \< 0.05.

RESULTS {#s3}
=======

In the CON group, the fiber-type composition ratio in the soleus muscles was 90.8% for type I myofibers and 9.2% for type II myofibers. In the HULT group, the fiber-type composition ratio in the soleus muscles was 72.9% for type I myofibers and 27.1% for type II myofibers ([Table 1](#tbl_001){ref-type="table"}Table 1.Ratio of fiber-type composition and number of apoptotic myofibersCONHULTRatio of fiber-type compositionType I90.8 ± 4.272.9 ± 5.4^†^Type II9.2 ± 4.227.1 ± 5.4^†^Number of active-caspase-3 positive myofibers03.0 ± 2.0^\*^The values are means ± standard deviation. P-values were assessed between the CON and HULT groups by unpaired student's t-test. \*Significant difference between the CON and HULT groups (p \< 0.05). †Significant difference between the CON and HULT groups (p \< 0.001).). Compared with the CON group, the composition ratio of type I myofibers decreased in the HULT group, whereas that of type II increased.

The rate of occurrence of caspase-3-expressed myofibers in the total number of myofibers in the HULT group was 0.27 ± 0.17%. Apoptotic myofibers were absent in the CON group, and this was accompanied by the presence of TUNEL-positive myonuclei and caspase-3 activation; on the other hand, apoptotic myofibers were present in the HULT group, which showed a statistically significant difference ([Table 1](#tbl_001){ref-type="table"}).

In the soleus muscles of the CON group, images of tissue staining for cathepsin-D showed two types of myofibers that could be clearly differentiated in terms of fluorescent intensity; some myofibers with low fluorescence intensity were observed, whereas myofibers with high fluorescence intensity predominated ([Fig. 1a](#fig_001){ref-type="fig"}Fig. 1.Conformity with fiber type and cathepsin-D expression by immunohistochemical analysis in the normal soleus muscle (a--c). Transverse serial sections of normal soleus muscles stained with anti-cathepsin-D and anti-fast myosin antibodies. The immunofluorescence of cathepsin-D is shown in green (a), and that of fast myosin is shown in red (b). The left panels show merged images for cathepsin-D and fast myosin (c). Arrows indicate the same myofibers as fiber type II myofibers expressing both weak immunofluorescence reactivity for cathepsin-D and a positive reaction for fast myosin in the serial sections. Arrowheads indicate the same myofibers as type I myofibers expressing strong immunofluorescence reactivity for cathepsin-D and a negative reaction for fast myosin in the serial sections. Scale bar: 20 μm.). Fluorescence signals of cathepsin-D were observed to have punctate patterns within myofibers within the vicinity of the sarcolemma, as well as within the sarcoplasm ([Fig. 1a, c](#fig_001){ref-type="fig"}).

The muscle tissues showed positive staining for fast myosin, which was in accordance with the myofibers with low fluorescence intensity of cathepsin-D, and in contrast, they demonstrated a negative reaction for fast myosin, which was consistent with the myofibers with a high fluorescence intensity for cathepsin-D ([Fig. 1a--c](#fig_001){ref-type="fig"}). Based on these results, myofibers with low fluorescence intensity for cathepsin-D were determined to be fast myosin-positive type II myofibers, and on the other hand, myofibers with high fluorescence intensity for cathepsin-D were determined to be fast myosin-negative type I myofibers.

In the serial cross sections of rat soleus muscles that had been subjected to hindlimb unloading in a low temperature environment for 3 weeks to induce apoptosis, decreased staining of the myonucleus, collapse of the fine network pattern of the sarcoplasm, and an obscure myocyte periphery, aggregated sarcoplasm, and fragments of denatured myofibers were observed by HE staining ([Fig. 2d, e](#fig_002){ref-type="fig"}Fig. 2.Conformity of cathepsin-D expression and apoptotic myofibers by immunohistochemical analysis in the soleus muscle of the CON (a--c) and HULT (d--l) groups. Transverse serial sections of the muscle were labeled with both anti-active caspase-3 antibody and TUNEL (a, f), both anti-dystrophin antibody and TUNEL (b, g), anti-cathepsin-D antibody (c, h, i, k), anti-active caspase-3 antibody (j), and fast myosin antibody (l). A higher magnification of panel e is depicted in panel i. Some of the serial sections were routinely stained with eosin--hematoxylin solution (d). Arrows indicate apoptotic myofibers expressing a positive reaction for both the active caspase-3 (red) and TUNEL-labeling (green) in serial sections (d--i) and a positive reaction for the active caspase-3 (red) in serial sections (j--l). Asterisks indicate type II myofibers exhibiting a negative reaction for both cathepsin-D (green) and positive reaction for fast myosin (green) in the serial sections (j--l). Arrowheads indicate a hybrid-type myofiber exhibiting a positive reaction for both cathepsin-D and fast myosin in the serial sections (j--l). Scale bar: 20 μm.).

A collapsed dystrophin, a protein that constitutes the sarcolemma, and disappearance of the line that forms the sarcolemma were observed in the myofibers that were positive for TUNEL labeling and active caspase-3 in immunofluorescence staining ([Fig. 2f, g](#fig_002){ref-type="fig"}). Therefore, these myofibers indicated the immunohistological features of apoptotic myofibers.

In these apoptotic myofibers, cathepsin-D was overexpressed, and images were observed in which cathepsin-D leaked from the lysosome or endoplasmic reticulum into the cytoplasm and was widely diffused ([Fig. 2h, i](#fig_002){ref-type="fig"}). The overexpression of cathepsin-D and its leakage into the sarcoplasm, as well as punctuate expression of cathepsin-D, were observed in caspase-3-active myofibers but were fuzzy in non-apoptotic, caspase-3-negative myofibers ([Fig. 2k](#fig_002){ref-type="fig"}). The caspase-3-active myofibers were type I myofibers that stained negative for fast myosin ([Fig. 2j, l](#fig_002){ref-type="fig"}).

In western blot analysis, generally, cathepsin-D in rodents is detected as an approximately 43 kDa preprocathepsin-D of inactive form that is cleaved and glycosylated to form an approximately 46 kDa procathepsin-D, a 28 kDa heavy chain, and a 15 kDa light chain[@r3], [@r23], [@r24]^)^. Bands of preprocathepsin-D and procathepsin-D, which are inactive forms of cathepsin-D, as well as the heavy chain, which is the active form of cathepsin-D, were observed in the soleus muscles of the CON and HULT groups ([Fig. 3a](#fig_003){ref-type="fig"}Fig. 3.Western blot analysis of cathepsin-D in tissue supernatant fluids from normal and degenerative soleus muscles. The three forms of cathepsin-D, which are preprocathepsin-D, procathepsin-D, and cathepsin-D mature form (heavy chain), were detected in the CON and HULT rats (a). Preprocathepsin-D level decreased in the HULT group (b). Procathepsin-D level showed no significant difference between the CON and HULT groups (c). The total inactive form of cathepsin-D, which is the amount of preprocathepsin-D and procathepsin-D, decreased in the HULT group (d), and the active form of cathepsin-D increased drastically in the HULT group (e). The results represent the mean ± SD. \*Significant difference between the CON and HULT groups (p \< 0.05). †Significant difference between the CON and HULT groups (p \< 0.001).). The light chain was not detected in these groups.

Compared with the CON group, the expression of preprocathepsin-D significantly decreased in the HULT group ([Fig. 3b](#fig_003){ref-type="fig"}). No significant difference in the expression of procathepsin-D was observed between the two groups ([Fig. 3c](#fig_003){ref-type="fig"}). The total expression of the inactive forms, namely, preprocathepsin-D and procathepsin-D, significantly decreased in the HULT group compared with that in the CON group ([Fig. 3d](#fig_003){ref-type="fig"}). On the other hand, the expression of the heavy chain in the HULT group significantly increased compared with that in the CON group ([Fig. 3e](#fig_003){ref-type="fig"}). Therefore, it was concluded that the amount of inactive cathepsin-D decreased in the atrophied muscles in the HULT group, whereas that of active cathepsin-D increased.

DISCUSSION {#s4}
==========

In the present study, two distinct types of myofibers were observed in rat soleus muscles, which showed a clear immunohistological difference in cathepsin-D fluorescence intensity. This difference in fluorescence intensity represented the abundance of antigen--antibody complex reactions of the anti-cathepsin-D antibody. Therefore, the observed strong fluorescence intensity of type I myofibers and the weak fluorescence intensity of type II myofibers are likely due to differences in cathepsin-D content, which depends on myofiber type, and this suggests that the cathepsin-D content in type I myofibers was higher than that in type II myofibers. Uchiyama et al.[@r25]^)^ reported that the content of the cathepsin group varies in each organ, and our results suggest that cathepsin-D concentrations were determined by the type of myofibers.

In the microscopic analysis, the expression of cathepsin-D in fiber type I myofibers was detected throughout transversely sectioned myofibers ([Fig. 1a](#fig_001){ref-type="fig"}). Early and late endosomes, phagosomes, and lysosomes in muscle are present in the sarcolemma and sarcoplasm[@r26]^)^. Preprocathepsin-D is synthesized in the rough endoplasmic reticulum, procathepsin-D is present in both the Golgi apparatus and prelysosomal compartments, single chain and mature cathepsin-D is present in lysosomes, and procathepsin D is distributed into them through the sarcoplasm[@r27]^)^. Hence, the detection of cathepsin-D in the present study is suggested to be a result of detecting all the cathepsin-D forms existing in the sarcolemma and sarcoplasm.

In contrast, myofibers in skeletal muscles can be classified as MHC-1, MHC-2A, MHC-2X/2D, and MHC-2B based on differences in myosin heavy chain (MHC) isoforms using methods such as electrophoresis and immunohistological staining[@r28], [@r29]^)^ and as types I, IIA, IIB, and IID (X), depending on the difference in myosin ATPase activity, using the myosin ATPase staining method[@r30],[@r31],[@r32],[@r33]^)^. Moreover, succinate dehydrogenase staining and nicotinamide tetrazolium reductase staining are known to classify myofibers as types I and II[@r34], [@r35]^)^. These identification methods are based on differences in MHC isoforms or mitochondrial enzyme activity, and no other method that identifies the type of myofibers has previously been established. Our findings demonstrated that the immunohistological staining of cathepsin-D was a useful method to clearly identify and classify myofibers into types I and II.

Tissues with high turnover rates of protein metabolism contain high levels of cathepsin-D[@r36]^)^, and the soleus muscle is known to contain high levels of myonucleus, ribosome, and total RNA compared with the extensor digitorum longus muscles[@r37]^)^. Based on these facts, one of the reasons why cathepsin-D was noticeably seen in type I myofibers compared with type II myofibers is presumed to be that type I myofibers have high protein metabolic turnover. Therefore, the strong fluorescence intensity of cathepsin-D in non-apoptotic myofibers of the HULT and CON groups seem to represent comprehensive results of slow MHC and protein expressions involved in the synthesis of slow MHC. The cathepsin-D is presumed to play a significant role in slow MHC synthesis and degradation.

In addition to MHC isoforms and protein metabolic turnover, type I and II myofibers are known to have distinct features such as their mitochondrial number, cytochrome c content, and nicotinamide adenine dinucleotide activity[@r38]^)^. Furthermore, myofibers with high oxidation capacity show higher cathepsin activity compared with myofibers with low oxidation capacity[@r39]^)^. Hence, one of the reasons why cathepsin-D fluorescence intensity was higher in type I myofibers than in type II myofibers is that type I myofibers have high rates of energy metabolism.

In the present study, the composition ratio of type I myofibers decreased in the HULT group, and western blot analysis revealed a decrease in the inactive-form cathepsin-D in the HULT group. In addition, the percentage of type I myofibers showing an extremely strong immunoreaction for cathepsin-D were decreased in the HULT rats, whereas type II myofibers showing a weak immunoreaction for cathepsin-D were increased in these rats. In disuse muscle atrophy, the turnover of muscle protein metabolism[@r40]^)^ and muscle energy metabolism[@r41]^)^ is lower, and the decrease in the level of inactive cathepsin-D observed in the present study may be caused by a decrease in the number of type I myofibers, increase in the number of type II myofibers, and decrease in the turnover rate of muscle protein metabolism and muscle energy metabolism. In addition, the fiber-type composition during development is known to transform from a fast type to a slow type, whereas that of muscle atrophy shifts from a slow type to a fast type[@r42],[@r43],[@r44]^)^. The reasons for this are assumed to be that the switch of MHC isoforms occurs within individual fibers and not by replacement with fibers of another fiber type[@r45], [@r46]^)^ and that the individual myofibers of muscle atrophy degenerate the individual myofibers. Hence, the alteration of fiber-type composition in the present study is considered to have resulted from transformation from slow MHC to fast MHC.

Although the actual amount of apoptosis occurring has not been previously reported, some apoptotic myofibers have been observed in the muscle of untreated aged rats[@r47]^)^. In contrast, apoptotic myofibers in normal muscles of the CON rats could not be found in our microscope observation. This result was mostly in agreement with other studies[@r48]^)^; the appearances of apoptotic myonuclei have been observed extremely rarely in the normal muscle of young adult rats. Immunofluorescence staining showed overexpression of cathepsin-D in caspase-3-active myofibers and leakage of it into the cytoplasm in the HULT group. Western blot analysis demonstrated an increase in the active-form cathepsin-D. In staurosporine-induced apoptosis in fibroblasts, cathepsin-D mediates cytochrome c release from the mitochondria and caspase-3 activation, and cytochrome c release and activation of caspase-9 and caspase-3 are inhibited by pepstatin A, which is a cathepsin-D inhibitor[@r49]^)^. In thallium-induced apoptosis of rat pheochromocytoma (PC12 cells), lysosome damage leads to the leakage of cathepsin-D into the cytoplasm, which triggers apoptosis via the degradation of Bid, a proapoptotic protein of the Bcl-2 family. This apoptotic event is known to be completely inhibited by pepstatin A, whereas E-64d, an inhibitor of cathepsin B, only partially inhibits apoptosis[@r50]^)^. Moreover, in naphthazarin-induced apoptosis in cultured myocardial cells, cathepsin-D leakage from the lysosome activates caspase-3[@r51]^)^, suggesting that cathepsin-D leakage into the cytoplasm causes cytochrome c release from mitochondria, activates caspase-9 and caspase-3, and further triggers apoptosis. The expression of apoptosis in the present study is therefore considered to be caused by caspase-3 activation due to cathepsin-D leakage.

In the present study, muscle lysate analysis detected a decrease in the inactive forms of cathepsin-D in the HULT group together with an increase in the active form. However, immunofluorescence staining showed overexpression of either the inactive or active form or both forms of cathepsin-D in apoptotic myofibers, which further leaked into the cytoplasm. In another study, when Y1-Ad12 cancer cells overexpressing the inactive form of cathepsin-D were treated with etoposide, a topoisomerase II inhibitor, cathepsin-D leaked into the cytoplasm, which was followed by the leakage of cytochrome c from the mitochondria and the activation of caspase-9 and caspase-3, and this resulted in an increase in the number of apoptotic cells[@r52]^)^. When the mature form or inactive form of cathepsin-D was microinjected into the cytoplasm of fibroblasts or HeLa cells, both the mature and inactive forms induced apoptosis[@r53]^)^. These results thus suggest that the expression of apoptosis is independent of the activation status of cathepsin-D and that the leakage of cathepsin-D into the cytoplasm is a key event. The expression mechanism of apoptosis in the present study is also considered to involve cathepsin-D leakage as a major event.

Lastly, the presence of cathepsin-D in the endoplasmic reticulum, endosome, or lysosome can be indicative of myofiber type and further suggests that cathepsin-D is involved in the mechanism governing the differentiation of myofiber types. In addition, apoptosis occurred in the soleus muscles that underwent hindlimb unloading in a low temperature environment in this study and cathepsin-D leakage appeared to play a key role in the mechanism of this apoptotic event.
